These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2904881)

  • 21. Expanded role of the dietitian in the Diabetes Control and Complications Trial: implications for clinical practice. The DCCT Research Group.
    Delahanty L; Simkins SW; Camelon K
    J Am Diet Assoc; 1993 Jul; 93(7):758-64, 767. PubMed ID: 8320401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
    Ann Intern Med; 1996 Feb; 124(4):379-88. PubMed ID: 8554246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetes.
    Jones TW; Borg WP; Borg MA; Boulware SD; McCarthy G; Silver D; Tamborlane WV; Sherwin RS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1713-8. PubMed ID: 9177369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Moss S
    Arch Intern Med; 1995 Apr; 155(7):745-54. PubMed ID: 7695463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive insulin therapy and weight gain in IDDM.
    Carlson MG; Campbell PJ
    Diabetes; 1993 Dec; 42(12):1700-7. PubMed ID: 8243815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes.
    Wing RR; Klein R; Moss SE
    Diabetes Care; 1990 Nov; 13(11):1106-9. PubMed ID: 2261822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
    ; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
    JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of bioelectrical impedance analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT).
    Leiter LA; Lukaski HC; Kenny DJ; Barnie A; Camelon K; Ferguson RS; MacLean S; Simkins S; Zinman B; Cleary PA
    Int J Obes Relat Metab Disord; 1994 Dec; 18(12):829-35. PubMed ID: 7894522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial.
    Delahanty LM; Halford BN
    Diabetes Care; 1993 Nov; 16(11):1453-8. PubMed ID: 8299434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight gain trajectories and obesity rates in intensive and conventional treatments of type 1 diabetes from the DCCT compared with a control population without diabetes.
    Carlson NE; Horton KW; Hokanson JE; Cleary PA; Jacobs DR; Brunzell JD; Purnell JQ;
    Diabet Med; 2022 May; 39(5):e14794. PubMed ID: 35040196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
    Duron F
    Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.
    de Boer IH; Kestenbaum B; Rue TC; Steffes MW; Cleary PA; Molitch ME; Lachin JM; Weiss NS; Brunzell JD;
    Arch Intern Med; 2008 Sep; 168(17):1867-73. PubMed ID: 18809813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus.
    Giordano C; Pantŏ F; Amato MP; Sapienza N; Pugliese A; Galluzzo A
    J Autoimmun; 1990 Oct; 3(5):611-7. PubMed ID: 2252529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential causes of weight gain in type 1 diabetes mellitus.
    Jacob AN; Salinas K; Adams-Huet B; Raskin P
    Diabetes Obes Metab; 2006 Jul; 8(4):404-11. PubMed ID: 16776747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The DCCT Research Group.
    Anderson EJ; Richardson M; Castle G; Cercone S; Delahanty L; Lyon R; Mueller D; Snetselaar L
    J Am Diet Assoc; 1993 Jul; 93(7):768-72. PubMed ID: 8320402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.
    Purnell JQ; Dev RK; Steffes MW; Cleary PA; Palmer JP; Hirsch IB; Hokanson JE; Brunzell JD
    Diabetes; 2003 Oct; 52(10):2623-9. PubMed ID: 14514648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic control and hypoglycaemia in the Illawarra area of NSW, Australia: a comparison with the DCCT.
    Moses R; Rodgers D; Griffiths R
    J Qual Clin Pract; 1995 Jun; 15(2):89-97. PubMed ID: 7670722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How have patients reacted to the implications of the DCCT?
    Thompson CJ; Cummings JF; Chalmers J; Gould C; Newton RW
    Diabetes Care; 1996 Aug; 19(8):876-9. PubMed ID: 8842607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.